New Drug Approved for Relapsed Lymphoma: Copanlisib New Drug Approved for Relapsed Lymphoma: Copanlisib

Patients with follicular lymphoma who have relapsed after at least two prior therapies now have a new option.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news